All Articles

A Healdsburg home is offered for $2M in Anthropic stock, a novel deal unlocking illiquid tech wealth for a rare, income-producing Wine Country asset.

A new study reveals a paradox in Canadian sport: women are leading boards like never before, but their numbers in top executive jobs have sharply fallen.

A top financial forum is urging a GST hike, corporate tax cuts, and a radical revamp of retirement savings in its bold 2026 federal budget proposal.

A new AI from India claims 98.79% accuracy in financial analysis by ditching a generalist approach, promising higher accuracy and lower costs.

A breakthrough 'pap smear for the pancreas' that detects early cancer has secured major funding, offering new hope against one of the deadliest diseases.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

Millions of women struggle with sleep, and hormones are the silent saboteur. Discover the science behind hormonal sleep disruption and expert-backed solutions.

In an unprecedented move, top executives from competing Washington wineries are joining forces. Can their 'One Voice' rewrite the state's future on the national stage?

A new platform combines gamification, DLT, and location tech to move beyond static rewards and capture the elusive engagement of modern consumers.

Struggling with losses, Nocera is betting its future on a $300M pivot into five of the world's most competitive tech sectors. Can it succeed?

As security tools drown in data, Niagara's new 600 Gbps platform offloads heavy processing to restore visibility and boost SOC/NOC efficiency.

Ohio is launching a massive, free AI training program, aiming to upskill thousands and position the state as a national leader in AI deployment.

A new partnership between Owl Cyber Defense and Foxguard aims to secure North America's power grid with hardware-enforced cybersecurity solutions.

Bristol's Huggg isn't just selling employee recognition; they're living it. Here's how their award-winning culture is setting a new industry standard.

A biotech firm's novel marine compound, now patented, shows promise in modulating key cell pathways, offering a new strategy against intractable diseases.

New York's Cyannova Capital debuts its inaugural fund in Hong Kong, aiming to connect North America, the Middle East, and Asia in frontier tech.

A skincare brand is challenging the FDA over sunscreen ingredients, revealing decades of regulatory delay and raising questions about what’s safe for our skin.

Neema Hospitality's 'Hotels for a Cure' campaign, driven by a family's battle with Parkinson's, turns summer travel into vital research support.

Crossroads Counselling expands psychoeducational testing to age 30, addressing a critical gap in care amid long public waits and high academic pressures.

A new report shows hospitals in a federal drug discount program provide less charity care than others, fueling calls for urgent federal reforms.